Lessons for China: Understanding the Role of Mobile Applications in China’S Response to COVID-19
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Emerging Leaders in Biosecurity Initiative
Emerging Leaders in Biosecurity Initiative Class of 2017 A competitive fellowship program created to identify, develop, and provide networking opportunities Yearbook for the next generation of leaders in biosecurity. Emerging Leaders in Biosecurity Initiative Contents Letter: 3 Thomas V. Inglesby, Director; Anita Cicero, Deputy Director, Johns Hopkins Center for Health Security Executive Steering Committee 5 Class of 2017 Fellows 9-35 ELBI 2017 Year in Review 36-37 ELBI Program Staff 41 ELBI Alumni 42 Cover and Inside Cover Photo Overlay: Swine Flu Strain Virus Particles. Col- orized transmission electron micrograph of negatively stained SW31 (swine strain) influenza virus particles. Credit: NIAID Emerging Leaders in Biosecurity Initiative The ELBI Fellowship program is made possible through financial support from the Open Philanthropy Project, under management by the Johns Hopkins Center for Health Security, and with the leadership of the ELBI Executive Steering Committee. For more information, please visit the ELBI website: http://www.centerforhealthsecurity.org/our-work/emergingbioleaders Center for Health Security “Modern conditions make the scenario of a global pandemic more likely. Humans are encroaching on animal environments, raising chances for pathogens to adapt from animals to people. An increasing share of the planet lives in megacities, heightening the likelihood of person-to-person transmission of pathogens. The movement of people and microbes around the globe is more efficient than ever. The recent outbreaks of SARS, MERS, and Ebola are only small glimpses of how quickly a deadly virus can spread.” Tom Inglesby and Benjamin Haas Foreign Affairs November 21, 2017 Middle East Respiratory Syndrome Coronavirus particle envelope proteins immunolabeled with Rabbit HCoV-EMC/2012 primary antibody and Goat an- 1 ti-Rabbit 10 nm gold particles. -
SYRA MADAD, D.H.Sc, M.Sc., MCP
SYRA MADAD, D.H.Sc, M.Sc., MCP Syra Madad, D.H.Sc., M.Sc., MCP is nationally recognized leader in public health and special pathogen preparedness and response. She is Senior Director, System-wide Special Pathogens Program at New York City Health + Hospitals, the nation’s largest municipal healthcare delivery system overseeing special pathogen preparedness and response efforts across 11 acute care hospitals in addition to post-acute/long-term care facilities and ambulatory care sites. She is Principal Investigator of NYC Health + Hospitals Center for Global Healthcare Preparedness to Special Pathogens. In addition, Dr. Madad is Core Faculty in the National Ebola Training and Education Center (NETEC), funded by the Centers for Disease Control and Prevention (CDC) and the Assistant Secretary for Preparedness and Response (ASPR) and Assistant Professor in the Graduate Biotechnology/Biodefense Program at the University of Maryland. She is an Alumni Fellow at Johns Hopkins Bloomberg School of Public Health, Center for Health Security’s Emerging Leaders in Biosecurity Program and the Federal Bureau of Investigation’s Behavioral Informatics & Technological Enterprise Studies Program. Dr. Madad earned her Doctoral degree in Health Science with a concentration in Global Health from Nova Southeastern University, graduating with Alpha Eta Health Science Honor Society status. She obtained her Master of Science degree in Biotechnology with a concentration in Biodefense and Biosecurity and Bachelor of Science degree in Psychology from the University of Maryland. Dr. Madad holds numerous professional certifications, licenses and training certificates including Master Continuity Practitioner Certification (FEMA), Advanced Emergency Planning Certification, All Hazard Response (CBRNE) Training for Laboratory Personnel, Biosafety Level III Training, and Identification of the Primary Select Agents of Bioterrorism Training. -
Clinical Laboratory Preparedness and Response Guide
TABLE OF CONTENTS Table of Contents ...................................................................................................................................................................................... 2 State Information ....................................................................................................................................................................................... 7 Introduction .............................................................................................................................................................................................. 10 Laboratory Response Network (LRN) .......................................................................................................................................... 15 Other Emergency Preparedness Response Information: .................................................................................................... 19 Radiological Threats ......................................................................................................................................................................... 21 Food Safety Threats .......................................................................................................................................................................... 25 BioWatch Program ............................................................................................................................................................................ 27 Bio Detection Systems -
Legal-Graphics' 6-26-21 COVID Timeline
Number of days since first sign of virus Overview: Year 2 of COVID Year 2 Nov. 23, 2020 Dec. 3, 2020 Dec. 11, 2020 Dec. 21, 2020 Dec. 30, 2020 Jan. 7, 2021 Jan.Jan. 14,7, 2021 2021 of COVID-19 Worldwide Worldwide Worldwide Worldwide Worldwide Worldwide Worldwide Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths over 1,400,000 over 1,500,000 over 1,600,000 over 1,700,000 over 1,800,000 over 1,900,000 over 1,900,0002,000,000 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 Link to Nov. 16, 2020 Nov. 18, 2020 Nov. 21, 2020 Nov. 25, 2020 Nov. 27, 2020 Nov. 30, 2020 Dec. 3, 2020 Dec. 6, 2020 Dec. 8, 2020 Dec. 11, 2020 Dec. 14, 2020 Dec. 17, 2020 Dec. 21, 2020 Dec. 22, 2020 Dec. 26, 2020 Dec. 29, 2020 Dec. 31, 2020 Jan. 3, 2021 Jan. 5, 2021 Jan. 8, 2021 Jan. 11, 2021 Jan. 13, 2021 Jan. 17, 2021 Source Moderna says data FDA allows US cases top Picture of US Demand for live Moderna to request Map showing US UK gears up for Chart of cumulative Pfizer vaccine to be How do the Pfizer Vaccinations reach How the Pfizer Vaccines across Could AZD7442 Map showing How vaccinations Interactive US Map It’s lockdown No. -
Framework for Equitable Allocation of COVID-19 Vaccine (2020)
THE NATIONAL ACADEMIES PRESS This PDF is available at http://nap.edu/25917 SHARE Framework for Equitable Allocation of COVID-19 Vaccine (2020) DETAILS 260 pages | 6 x 9 | PAPERBACK ISBN 978-0-309-68224-4 | DOI 10.17226/25917 CONTRIBUTORS GET THIS BOOK Helene Gayle, William Foege, Lisa Brown, and Benjamin Kahn, Editors; Committee on Equitable Allocation of Vaccine for the Novel Coronavirus; Board on Health Sciences Policy; Board on Population Health and Public Health Practice; Health FIND RELATED TITLES and Medicine Division; National Academies of Sciences, Engineering, and Medicine; National Academy of Medicine SUGGESTED CITATION National Academies of Sciences, Engineering, and Medicine 2020. Framework for Equitable Allocation of COVID-19 Vaccine. Washington, DC: The National Academies Press. https://doi.org/10.17226/25917. Visit the National Academies Press at NAP.edu and login or register to get: – Access to free PDF downloads of thousands of scientific reports – 10% off the price of print titles – Email or social media notifications of new titles related to your interests – Special offers and discounts Distribution, posting, or copying of this PDF is strictly prohibited without written permission of the National Academies Press. (Request Permission) Unless otherwise indicated, all materials in this PDF are copyrighted by the National Academy of Sciences. Copyright © National Academy of Sciences. All rights reserved. Framework for Equitable Allocation of COVID-19 Vaccine Framework for Equitable Allocation of COVID-19 Vaccine Helene Gayle, William Foege, Lisa Brown, and Benjamin Kahn, Editors Committee on Equitable Allocation of Vaccine for the Novel Coronavirus Board on Health Sciences Policy Board on Population Health and Public Health Practice Health and Medicine Division PREPUBLICATION COPY: UNCORRECTED PROOFS Copyright National Academy of Sciences. -
SYRA MADAD, D.H.Sc, M.Sc., MCP
SYRA MADAD, D.H.Sc, M.Sc., MCP Syra Madad, D.H.Sc., M.Sc., MCP is nationally recognized public health leader and epidemiologist in infectious disease and special pathogen preparedness and response. She is Senior Director, System-wide Special Pathogens Program at New York City Health + Hospitals, the nation’s largest municipal healthcare delivery system overseeing special pathogen preparedness and response efforts across 11 acute care hospitals in addition to post-acute/long-term care facilities and ambulatory care sites. She is Principal Investigator of NYC Health + Hospitals Institute of Diseases and Disaster Management and Health & Safety Lead of the Enhanced Special Investigations Unit of NYC Test & Trace Corp. In addition, Dr. Madad is Core Faculty in the National Emerging Special Pathogens Training and Education Center (NETEC), funded by the Centers for Disease Control and Prevention (CDC) and the Assistant Secretary for Preparedness and Response (ASPR). She is a Fellow at Harvard University’s Belfer Center for Science and Select Media Highlights on Dr. International Affairs, Adjunct Senior Fellow at the Federation of American Madad: • Fortune 40 Under 40 Scientists and part of their COVID19 Taskforce, Alumni Fellow at Johns • Netflix’s Pandemic: How to Prevent Hopkins Bloomberg School of Public Health, Center for Health Security’s an Outbreak Emerging Leaders in Biosecurity Program and Alumni Senior Fellow in the • Discovery The Vaccine: Conquering COVID Federal Bureau of Investigation’s Behavioral Informatics & Technological • Elemental 50 Experts to Trust in a Enterprise Studies Program. Pandemic • NY Magazine Feature on Dr. Syra Dr. Madad earned her Doctoral degree in Health Science with a Madad concentration in Global Health from Nova Southeastern University, • CNN: Disease Detectives graduating with Alpha Eta Health Science Honor Society status. -
Frontline Hospital Planning Guide for Special Pathogens
FRONTLINE HOSPITAL PLANNING GUIDE: SPECIAL PATHOGENS JUNE 2019 EMERGENCY MANAGEMENT Background: NYC Health + Hospitals is the largest municipal healthcare delivery system in the United States, providing essential inpatient, outpatient, and home-based services to more than one million New Yorkers every year in more than 70 locations across the city’s five boroughs. With our unique experiences in responding to emerging, re-emerging, and high consequence infectious disease incidents, including safely and successfully treating NYC’s single, confirmed case of Ebola virus disease and numerous persons under investigation, we understand first-hand the myriad impacts infectious disease threats and special pathogens events have on healthcare delivery. With the increasing demand for preparedness for and responses to the world’s emerging public health threats, this planning guide breaks new ground and leads the way as a distinctive domestic resource for healthcare delivery systems to customize their plans specific to their unique clinical, operational, and financial needs. Purpose and Audience: All hospitals must be prepared to identify and isolate a patient presenting with a suspected special pathogen infection (i.e., one that is particularly virulent and requires care processes and personal protective equipment beyond daily infection control practices) and inform internal and external stakeholders. This document provides high level planning guidance for a frontline hospital multidisciplinary team (e.g., emergency management, infection prevention and control, emergency department, inpatient care, safety, public relations, and infectious disease, depending on the resources and role of the facility in the community) to support planning and training for the provision of initial care to such patients while determining whether and when the patient will be transferred to another facility for further assessment and treatment. -
Los Ángeles 11-13 De Junio 2019
INFORME IF DE FERIAS 2019 E3 Los Ángeles 11-13 de junio 2019 Oficina Económica y Comercial de la Embajada de España en Los Angeles Este documento tiene carácter exclusivamente informativo y su contenido no podrá ser invocado en apoyo de ninguna reclamación o recurso. ICEX España Exportación e Inversiones no asume la responsabilidad de la información, opinión o acción basada en dicho contenido, con independencia de que haya realizado todos los esfuerzos posibles para asegurar la exactitud de la información que contienen sus páginas. INFORME IF DE FERIAS 20 de agosto de 2019 Los Angeles Este estudio ha sido realizado por Jorge Verdejo Bermejo y Senín Carbia Coucheiro Bajo la supervisión de la Oficina Económica y Comercial de la Embajada de España en Los Ángeles. Editado por ICEX España Exportación e Inversiones, E.P.E., M.P. NIPO: 114-19-041-8 IF E3 2019 Índice 1. Perfil de la Feria 4 1.1. Ficha técnica 4 2. Descripción y evolución de la Feria 6 2.1. Participación general 6 2.2. Participación española 8 2.2.1. Empresas españolas 8 2.2.2. Representación de ICEX 8 3. Tendencias y novedades presentadas 9 4. Valoración 11 3 Oficina Económica y Comercial de la Embajada de España en Los Angeles IF E3 2019 1. Perfil de la Feria E3 es una de las mayores ferias del mundo en videojuegos y productos relacionados, como videoconsolas. En esta feria, celebrada anualmente en la ciudad de Los Ángeles, se reúnen las principales empresas de la industria del videojuego y del entretenimiento en general. -
Local Community Partners to Provide Thanksgiving Groceries to Food
WEDNESDAY Fire Hazard Holiday Travel Fire weather to return to Millions stick to Southern California by Thanksgiving travel 11.25.20 holiday. plans despite warnings. Volume 20 Issue 11 Page 2 Page 5 @smdailypress @smdailypress Santa Monica Daily Press smdp.com Clara Harter GOLIATH: Cast and crew members with the popular television show “Goliath” stopped by the Ocean Lodge Hotel Tuesday to film scenes for the series’ upcoming season. “Goliath” follows Billy McBride, a formerly high-powered attorney who lives at the Ocean Lodge, as he rebuilds his legal career by taking on giant corporations and powerful billionaires. The char- acter, which is portrayed by Billy Bob Thornton, hangs out at the neighboring Chez Jay, a storied bar and restaurant that was built around the same time as the hotel and also happens to be where show creator David E. Kelley met his wife Michelle Pfeiffer. Local community partners to California officials issue provide Thanksgiving groceries to dire warnings about virus food-insecure families spread BY BRIAN MELLEY AND Barbara Ferrer. “Inaction in the face More than a thousand families CHRISTOPHER WEBER of this devastating acceleration of from the local community left Santa Associated Press cases will cause irreparable harm.” Monica College Tuesday with holiday Ferrer told supervisors that a meals consisting of fresh turkey, Los Angeles County supervisors proposed stay-home order would pumpkin pie and more as a result of voted Tuesday against allowing be more modest than a statewide the inaugural Giving Thanks(giving) restaurants to remain open for closure in the spring but was drive-thru event. -
Legal-Graphics' 5-17-21 COVID Timeline
Number of days since Overview: Year 2 of COVID first sign of virus Year 2 Nov. 23, 2020 Dec. 3, 2020 Dec. 11, 2020 Dec. 21, 2020 Dec. 30, 2020 Jan. 7, 2021 Jan.Jan. 14,7, 2021 2021 of COVID-19 Worldwide Worldwide Worldwide Worldwide Worldwide Worldwide Worldwide Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths over 1,400,000 over 1,500,000 over 1,600,000 over 1,700,000 over 1,800,000 over 1,900,000 over 1,900,0002,000,000 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 Link to Nov. 16, 2020 Nov. 18, 2020 Nov. 21, 2020 Nov. 25, 2020 Nov. 27, 2020 Nov. 30, 2020 Dec. 3, 2020 Dec. 6, 2020 Dec. 8, 2020 Dec. 11, 2020 Dec. 14, 2020 Dec. 17, 2020 Dec. 21, 2020 Dec. 22, 2020 Dec. 26, 2020 Dec. 29, 2020 Dec. 31, 2020 Jan. 3, 2021 Jan. 5, 2021 Jan. 8, 2021 Jan. 11, 2021 Jan. 13, 2021 Jan. 17, 2021 Source Moderna says data FDA allows US cases top Picture of US Demand for live Moderna to request Map showing US UK gears up for Chart of cumulative Pfizer vaccine to be How do the Pfizer Vaccinations reach How the Pfizer Vaccines across Could AZD7442 Map showing How vaccinations Interactive US Map It’s lockdown No. -
CD Projekt Equity Research Division
CD Projekt Equity Research Division Target Price: PLN 209.1 Current Price: PLN 277.9 Downside Potential: 24.8% Recommendation: SELL Investment Horizon: 1 Year Vienna, 31th January 2020 Team Overview Equity Research Lisa Viktoria Miika Konstantin Höss Weissova Ihamäki Dungl Head of Associate Analyst Analyst Equity Research ▪ Task Distribution ▪ Business Model ▪ Forecasts ▪ Research ▪ Presentation ▪ Industry Research ▪ Valuation ▪ Forecasts ▪ Forecasts ▪ Presentation ▪ BSc. (WU) ▪ BSc. (WU) – 3rd Semester ▪ MSc. (Hanken) – 2nd Semester ▪ BSc. (WU) – 5th Semester - 2 - © WUTIS Agenda 1 Investment Thesis 5 2 Business Overview 6 3 Market & Industry Overview 11 4 Financial Analysis 15 5 Valuation 17 6 Risk Analysis 21 7 Conclusion 24 8 Appendix 26 - 3 - © WUTIS Share Price Performance CDP has gained more than 1,300% in the last four years, especially after E3 announcements [5] [6] Share price – Major Events PLN 300 [4] ▪ [1] May 31, 2016 (+212.7%) – The second Witcher 3 DLC is released by CDP ▪ [1] June 14, 2016 (v.s.) – CDP announces PLN 250 GWENT at E3 2016 ▪ [2] August 2017 (+7.5%) – CDP announces Thronebreaker at gamescom 2017. PLN 200 [3] ▪ [3] June 14, 2018 (+212.7%) – Cyberpunk [2] 2077 wins over one hundred awards at the E3 2018 and the second game trailer is published PLN 150 ▪ [4] October to December (-30.6%) – GWENT [1] and Thronebreaker are released for PC, PS4 and XBO. The latter did not meet sales PLN 100 expectations. ▪ [5] October 29, 2019 (+8.4%) – GWENT: The Witcher Card Game is released for iOS. PLN 50 ▪ [6] January 17, 2020 (-5.7%) – CDP delays the publishing date of Cyberpunk 2077 from April 2020 to September 17, 2020 and its PLN 0 online mode to after 2021. -
Interactive, Hands-On Training for Hospital Workers Increases Level of Special Pathogen Preparedness
Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 22 February 2021 doi:10.20944/preprints202102.0448.v1 Interactive, hands-on training for hospital workers increases level of special pathogen preparedness Authors: Eleanor Tolf Intern, System-wide Special Pathogens Program, NYC Health + Hospitals Georgetown University, B.S. Syra Madad, DHSc, MSc and MCP Senior Director, System-wide Special Pathogens Program, NYC Health + Hospitals For correspondence: Syra Madad NYC Health + Hospitals 125 Worth Street, Suite 412 New York, NY 10013 [email protected] Short running title: Interactive training increases SP preparedness. Abstract Objective: The purpose of this evaluation is to determine the effect of intensive, interactive training on hospital workers’ preparedness for special pathogen cases by utilizing the Frontline Facility Special Pathogens Training Course created by New York City Health + Hospitals (NYC H+H). Methods: An 8-hour, bi-monthly course conducted between 2018 and 2019 was offered to health care employees throughout the United States Department of Health and Human Services Region 2, mostly from NYC H+H. Evaluation included multiple choice pre and post exams, a 26-question survey about level of preparedness before and after the training, and follow up interviews focused on changes in facility protocols. Results: 61% of survey respondents indicated that they had never attended a hospital-sponsored special pathogens training before. After the training, there was a 53.3% report rate of feeling “very prepared,” compared to 14.6% before the training. Additionally, there was an 11% improvement in test scores. 77% of respondents also reported that their facility had changed protocols or processes relating to topics covered in the course after their training date.